Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Dialysis Procedures Alter Metabolic Conditions
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
2017 (English)In: Nutrients, ISSN 2072-6643, E-ISSN 2072-6643, Vol. 9, no 6, article id 548Article, review/survey (Refereed) Published
Abstract [en]

A progressive chronic kidney disease results in retention of various substances that more or less contribute to dysfunction of various metabolic systems. The accumulated substances are denominated uremic toxins. Although many toxins remain undetected, numerous newly defined toxins participate in the disturbance of food breakdown. In addition, toxic effects may downregulate other pathways, resulting in a reduced ability of free fatty acid breakdown by lipoprotein lipase (LPL) and hepatic lipase (HL). Dialysis may even worsen metabolic functions. For LPL and HL, the use of heparin and low molecular weight heparin as anticoagulation during hemodialysis (HD) initiate a loss of these enzymes from their binding sites and degradation, causing a temporary dysregulation in triglyceride breakdown. This lack of function will cause retention of the triglyceride containing lipids for at least 8 h. In parallel, the breakdown into free fatty acids is limited, as is the energy supply by them. This is repeated thrice a week for a normal HD patient. In addition, dialysis will cause a loss of amino acids and disturb glucose metabolism depending on the dialysates used. The addition of glucose in the dialysate may support oxidation of carbohydrate and the retention of Amadori products and subsequent tissue alterations. To avoid these effects, it seems necessary to further study the effects of anticoagulation in HD, the extent of use of glucose in the dialysate, and the supplementation of amino acids.

Place, publisher, year, edition, pages
MDPI AG , 2017. Vol. 9, no 6, article id 548
Keywords [en]
malnutrition, lipids, lipase, heparin, dialysis, hemodialysis, peritoneal dialysis, glycation end products, glucose
National Category
Nutrition and Dietetics
Identifiers
URN: urn:nbn:se:umu:diva-140241DOI: 10.3390/nu9060548ISI: 000404177100019OAI: oai:DiVA.org:umu-140241DiVA, id: diva2:1150571
Available from: 2017-10-19 Created: 2017-10-19 Last updated: 2018-06-09Bibliographically approved

Open Access in DiVA

fulltext(614 kB)13 downloads
File information
File name FULLTEXT01.pdfFile size 614 kBChecksum SHA-512
c550356f075829f19542824ccf1d07ec51996c127bb6da17d8469a871ec2e2050ac9dcfe86f0995d4204b1be5839ce1d0b78ad6608b92bf9cc8494c7062273ec
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Stegmayr, Bernd
By organisation
Medicine
In the same journal
Nutrients
Nutrition and Dietetics

Search outside of DiVA

GoogleGoogle Scholar
Total: 13 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 42 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf